Abstract:Background Most of the structural modifications to evodiamine (EVO) have focused on the 3- and 10-positions, while structural modifications to the EVO 2-position have not yet been reported. In this study, we investigated the scaffold diversity and bioactivity of EVO from position 2 to gain more insight into the influence of the chemical space around EVO on bioactivity. Objective The study aims to synthesize two derivatives of EVO with hydroxy groups, 8a and 8b, and to investigate the antitumor activity of EVO derivatives with hydroxy groups compared to EVO. Methods The synthesized compounds were structurally characterized by H-1 NMR, C-13 NMR, and mass spectrometry. The effects of compounds 8a, 8b, and EVO on the proliferation of H460, A549, and Eca109 cells in vitro were determined by MTT. The effect of EVO, 8a and 8b on apoptosis of H460 cells was investigated by the annexed V-FITC/propidium iodide (PI) combination assay. The expression of EVO, 8a and 8b on apoptosis-related proteins was examined by Western blot analysis. To simulate the binding ability between small molecules and proteins, molecular docking calculations of EGFR(WT) and EGFR(T790M) with 8a and 8b, respectively, were performed using Schrodinger software. Results In the cytotoxicity assay, compound 8b showed lower IC50 values for the three tumor cell lines (6.69 & mu;M for H460 cells, 20.02 & mu;M for A549 cells, and 16.47 & mu;M for Eca109 cells) compared to compound 8a and EVO, and 8b induced apoptosis by affecting apoptosis-related proteins CRAF, AKT, and ERK in a late apoptotic manner. The molecular docking results showed that 8b has a good binding ability to EGFR upstream of apoptosis-related proteins. Conclusion These findings suggest that 8b has significantly higher antitumor biological activity than EVO and 8a. This antitumor effect has important implications for the study of EVO derivatives in antitumor models.

Synthesis and Antitumor Activity of Evodiamine Derivatives with Nitro, Amino, and Methoxy Groups

The Design, Synthesis, and Evaluation of Evodiamine Derivatives with Hydroxy Groups

The Design, Synthesis, and Evaluation of Evodiamine Derivatives with Hydroxyl Groups

New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives As Novel Antitumor Agents by Systemic Structure-Activity Relationship Analysis and Biological Evaluations.

Synthesis , in vitro and in vivo antitumor activity and docking studies of new evodiamine derivatives

Design, synthesis, and biological evaluation of 3,4,5-trimethoxy evodiamine derivatives as potential antitumor agents

Design, Synthesis and Bioactivity Evaluation of Novel N-phenyl-substituted Evodiamine Derivatives As Potent Anti-Tumor Agents

Optical Evodiamine Derivatives：asymmetric Synthesis and Antitumor Activity

Design, Synthesis And Evaluation Of N13-Substituted Evodiamine Derivatives Against Human Cancer Cell Lines

Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Structure-activity Relationship Study of Novel Evodiamine Amino Acid Conjugates with Potent Anti-Colorectal Cancer Efficacy

Antitumor Activity and Theoretical Calculation of Evodiamine and Rutaecarpine

Design, Synthesis and Biological Evaluation of E-Ring Modified Evodiamine Derivatives As Novel Antitumor Agents

Discovery of Novel Bis-Evodiamine Derivatives with Potent Antitumor Activity.

Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy

Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives As Potential Antihepatocellular Carcinoma Agents

Design, Synthesis, and Biological Evaluation of Evodiamine-Indolequinone Hybrids As Novel NQO1 Agonists Against Non-Small Cell Lung Cancer

A Concise Synthesis and Biological Study of Evodiamine and Its Analogues

Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer

Research on Anti-Tumor Activity of Evodiamine in Vitro